WHO Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasm (GEP-NEN): Data from 358 Patients of the Spanish Group of Neuroendocrine and Endocrine Tumors Registry (R-GETNE)


Introduction: RGETNE national NEN Registry comprises 74 hospitals from all regions of Spain.

Aim(s): To present an updated report on epidemiology, clinico-pathological features, patterns of care and clinical outcome of a series of 358 G3 GEP-NEN patients diagnosed since 2000

Materials and methods: Data was provided online (http://www.rgetne.net) by investigators and assessed for internal consistency by external independent reviewers. On-site data monitoring/audit was performed in top recruiting centres.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Garcia Carbonero R, Jimenez-Fonseca P, Benavent M, Alonso V, Crespo G,

Keywords: G3 NEN, epidemiology, survival, patterns of care, response to chemotherapy,

To read the full abstract, please log into your ENETS Member account.